BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29055924)

  • 1. Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients.
    Toson EA; Shiha GE; Abdelgaleel AE
    Ann Hepatol; 2017 November-December,; 16(6):862-873. PubMed ID: 29055924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.
    Fouad SA; Esmat S; Omran D; Rashid L; Kobaisi MH
    World J Gastroenterol; 2012 Jun; 18(23):2988-94. PubMed ID: 22736923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients.
    Attallah AM; Omran D; Omran MM; Albannan MS; Zayed RA; Saif S; Farid A; Hassany M; Yosry A
    Br J Biomed Sci; 2018 Jan; 75(1):19-23. PubMed ID: 28945150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.
    Schiavon LL; Narciso-Schiavon JL; Carvalho Filho RJ; Sampaio JP; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
    J Viral Hepat; 2008 Sep; 15(9):666-74. PubMed ID: 18482283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hyaluronic acid, its degrading enzymes, degradation products, and ferritin in the assessment of fibrosis stage in Egyptian patients with chronic hepatitis C.
    El-mezayen HA; Toson el-SA; Shiha GE
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):69-76. PubMed ID: 23011038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
    Kim SM; Sohn JH; Kim TY; Roh YW; Eun CS; Jeon YC; Han DS; Oh YH
    Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
    Omran MM; Farid K; Emran TM; Attallah AA
    Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.
    Ozel BD; Poyrazoğlu OK; Karaman A; Karaman H; Altinkaya E; Sevinç E; Zararsiz G
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):895-900. PubMed ID: 25951491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APRI test and hyaluronic acid as non-invasive diagnostic tools for post HCV liver fibrosis: Systematic review and meta-analysis.
    El Serafy MA; Kassem AM; Omar H; Mahfouz MS; El Said El Raziky M
    Arab J Gastroenterol; 2017 Jun; 18(2):51-57. PubMed ID: 28579340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibro-check: a combination of direct and indirect markers for liver fibrosis staging in chronic hepatitis C patients.
    Attallah AM; El-Far M; Abdel Malak CA; Omran MM; Farid K; Hussien MA; Albannan MS; Attallah AA; Elbendary MS; Elbesh DA; Elmenier NA; Abdallah MO
    Ann Hepatol; 2015; 14(2):225-33. PubMed ID: 25671832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
    Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
    Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C.
    Amorim TG; Staub GJ; Lazzarotto C; Silva AP; Manes J; Ferronato Mda G; Shiozawa MB; Narciso-Schiavon JL; Dantas-Correa EB; Schiavon Lde L
    Ann Hepatol; 2012; 11(6):855-61. PubMed ID: 23109448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FibroScan, APRI, FIB4, and GUCI: Role in prediction of fibrosis and response to therapy in Egyptian patients with HCV infection.
    Yosry A; Fouad R; Alem SA; Elsharkawy A; El-Sayed M; Asem N; Hassan E; Ismail A; Esmat G
    Arab J Gastroenterol; 2016 Jun; 17(2):78-83. PubMed ID: 27353055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients?
    Resino S; Bellón JM; Asensio C; Micheloud D; Miralles P; Vargas A; Catalán P; López JC; Alvarez E; Cosin J; Lorente R; Muñoz-Fernández MA; Berenguer J
    BMC Infect Dis; 2010 Aug; 10():244. PubMed ID: 20723207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of T lymphocyte subpopulations in assessment of liver fibrosis stages in hepatitis C virus patients: simple noninvasive score.
    Toson el-SA; Shiha GE; El-Mezayen HA; El-Sharkawy AM
    Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):931-9. PubMed ID: 27159125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
    Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
    Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection.
    Cross TJ; Calvaruso V; Maimone S; Carey I; Chang TP; Pleguezuelo M; Manousou P; Quaglia A; Grillo F; Dhillon AP; Dusheiko GM; Burroughs AK; Harrison PM
    J Viral Hepat; 2010 Aug; 17(8):546-54. PubMed ID: 19874477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.
    Holmberg SD; Lu M; Rupp LB; Lamerato LE; Moorman AC; Vijayadeva V; Boscarino JA; Henkle EM; Gordon SC;
    Clin Infect Dis; 2013 Jul; 57(2):240-6. PubMed ID: 23592832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
    Sheptulina A; Shirokova E; Nekrasova T; Blum H; Ivashkin V
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1956-1962. PubMed ID: 27059170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
    Parise ER; Oliveira AC; Figueiredo-Mendes C; Lanzoni V; Martins J; Nader H; Ferraz ML
    Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.